DOW JONES28,062.20+101.40 0.36%
S&P 5003,236.21+10.32 0.32%
NASDAQ9,261.59+40.31 0.44%

Bank of America Initiates Coverage On Immunomedics with Buy Rating, Announces $26 Price Target

Bank of America analyst Tazeen Ahmad initiates coverage on Immunomedics (NASDAQ:IMMU) with a Buy rating and a $26 price target.

Benzinga · 12/20/2019 17:04

Bank of America analyst Tazeen Ahmad initiates coverage on Immunomedics (NASDAQ:IMMU) with a Buy rating and a $26 price target.